BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21896368)

  • 1. Drugs and diagnostic innovations to improve global health.
    Peeling RW; Nwaka S
    Infect Dis Clin North Am; 2011 Sep; 25(3):693-705, xi. PubMed ID: 21896368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Government action needed to step up research and development for world's most neglected diseases.
    Pecoul B
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):841-3. PubMed ID: 16307495
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug discovery and developments in developing countries: bottlenecks and way forward.
    Nyigo VA; Malebo HM
    Tanzan Health Res Bull; 2005 Sep; 7(3):154-8. PubMed ID: 16941941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical issues in funding research and development of drugs for neglected tropical diseases.
    Oprea L; Braunack-Mayer A; Gericke CA
    J Med Ethics; 2009 May; 35(5):310-4. PubMed ID: 19407037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on stimulating industrial research and development for neglected infectious diseases.
    Webber D; Kremer M
    Bull World Health Organ; 2001; 79(8):735-41. PubMed ID: 11545330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial lessons from public-private partnerships in drug and vaccine development.
    Wheeler C; Berkley S
    Bull World Health Organ; 2001; 79(8):728-34. PubMed ID: 11545329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirements for high impact diagnostics in the developing world.
    Urdea M; Penny LA; Olmsted SS; Giovanni MY; Kaspar P; Shepherd A; Wilson P; Dahl CA; Buchsbaum S; Moeller G; Hay Burgess DC
    Nature; 2006 Nov; 444 Suppl 1():73-9. PubMed ID: 17159896
    [No Abstract]   [Full Text] [Related]  

  • 9. Building local research and development capacity for the prevention and cure of neglected diseases: the case of India.
    Kettler HE; Modi R
    Bull World Health Organ; 2001; 79(8):742-7. PubMed ID: 11545331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-genomic challenges for collaborative research in infectious diseases.
    Okeke IN; Wain J
    Nat Rev Microbiol; 2008 Nov; 6(11):858-64. PubMed ID: 18711428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An audience with... Victoria G. Hale.
    Hale VG
    Nat Rev Drug Discov; 2005 Nov; 4(11):878. PubMed ID: 16299916
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of human parasitic diseases: Context and overview.
    Molyneux DH
    Adv Parasitol; 2006; 61():1-45. PubMed ID: 16735161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New strategies for innovation in global health: a pharmaceutical industry perspective.
    Witty A
    Health Aff (Millwood); 2011 Jan; 30(1):118-26. PubMed ID: 21209447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis control and research strategies for the 1990s: memorandum from a WHO meeting.
    Bull World Health Organ; 1992; 70(1):17-21. PubMed ID: 1568278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Public-private partnerships: new ways to discover, develop and deliver drugs for tropical diseases.
    Hentschel CC
    Southeast Asian J Trop Med Public Health; 2004; 35 Suppl 2():1-4. PubMed ID: 15906625
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmaceutical development concerning diseases predominating in tropical regions: the concept of indigent drugs].
    Trouiller P; Rey JL; Bouscharain P
    Ann Pharm Fr; 2000 Jan; 58(1):43-6. PubMed ID: 10669812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembling a global vaccine development pipeline for infectious diseases in the developing world.
    Serdobova I; Kieny MP
    Am J Public Health; 2006 Sep; 96(9):1554-9. PubMed ID: 16873743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Democratizing molecular diagnostics for the developing world.
    Abou Tayoun AN; Burchard PR; Malik I; Scherer A; Tsongalis GJ
    Am J Clin Pathol; 2014 Jan; 141(1):17-24. PubMed ID: 24343733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public-private partnerships for health: their main targets, their diversity, and their future directions.
    Widdus R
    Bull World Health Organ; 2001; 79(8):713-20. PubMed ID: 11545327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.